Should R. Ph.s join class action lawsuits?

SF 383 prohibits PBMs from limiting patient choice of pharmacy, unfairly excluding pharmacies from networks, and forces them to reimburse pharmacies no less than what they pay affiliated pharmacies for the same drug.

Dae Lee, PharmD, Esq, CPBS and Lucas Morgan, Esq, discuss PBM and board of pharmacy enforcement actions, trends in PBM audits, and more.

US Senators on both sides of the aisle came together to announce the Protecting Pharmacies in Medicaid Act.

Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.

Along with discount drug card company GoodRx, the suit is aimed at CVS Caremark, Express Scripts, MedImpact Healthcare Systems, and Navitus Health Solutions.

The Federal Trade Commission released its second interim staff report on industry-leading pharmacy benefit managers and their practices specifically regarding specialty drugs.